GL1X · GenesisL1 explorer

Research workbench

Ctx-M-9 S70G in complex with hydrolyzed piperacillin

Analyse Ctx-M-9 S70G in complex with hydrolyzed piperacillin in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3Q1F
Type
protein
Length
522 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9L5C8
Ligands
YPP
Pockets
2 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26244% helix, 19% strandQ9L5C8
BBeta-lactamase (EC 3.5.2.6)protein26044% helix, 20% strandQ9L5C8

Ligands and binding sites

  • YPP · Hydrolyzed piperacillin · ligand · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11030.390.7621YPP
2960.360.7522YPP

Interfaces

1 interface between chains.

  • A–B · 71 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 3Q1F · CTX-M-9 S70G in complex with hydrolyzed piperacillin · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.